Ethnopharmacology relevance Central nervous system (CNS) diseases can be diverse and
usually present with comorbidity, as in the case of depression and anxiety. Despite …

Serotonergic psychedelic drugs, such as psilocin (4-hydroxy-N, N-dimethyltryptamine),
profoundly alter the quality of consciousness through mechanisms which are incompletely …

HT 2A receptor is a member of the family A G-protein-coupled receptor. It is involved in many
psychiatric disorders, such as depression, addiction and Parkinson's disease. 5-HT 2A R …

The anxiolytic and sedative-like effects of 3-methyl-1, 2, 3, 4, 5, 6-hexahydroazepino [4, 5-b]
indole (DM506), a non-hallucinogenic compound derived from ibogamine, were studied in …

(1) From mouse to man, shaking behavior (head twitches and/or wet dog shakes) is a
reliable readout of psychedelic drug action. Shaking behavior like psychedelia is thought to …

Objective To explore the specific alterations of white matter microstructure in children with
attention-deficit/hyperactivity disorder (ADHD) by automated fiber quantification (AFQ) and …

There is increasing interest in the therapeutic potential of psilocybin. In rodents, the
serotonin precursor, 5-hydroxytryptophan (5-HTP) and psilocybin induce a characteristic 5 …

The discovery of REM sleep is attributed to the landmark observations of Eugene Aserinsky
and Nathaniel Kleitman. In 1953, they identified periods of „active sleep‟ that are marked by …

Serotonergic psychedelic drugs, such as psilocin (4-hydroxy-N, N-dimethyltryptamine),
profoundly alter the quality of consciousness through mechanisms which are incompletely …

The purpose of this study was to investigate potential associations between psychological
flexibility (PF) and characteristics of the psychedelic experience: self-perceived meaningful …